1 – 61 of 61
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain
(
- Contribution to journal › Article
-
Mark
The density of anionic lipids modulates the adsorption of α-Synuclein onto lipid membranes
(
- Contribution to journal › Article
- 2023
-
Mark
Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats
(
- Contribution to journal › Article
-
Mark
Precision mapping of gene expression and proteins in the brain using gene editing and barcoded viral vectors
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2022
-
Mark
Tau, bridging the gap between Alzheimer's and Parkinson's diseases
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Automated quantification of neuronal swellings in a preclinical rodent model of Parkinson's disease detects region-specific changes in pathology
(
- Contribution to journal › Article
-
Mark
Alpha-synuclein: pathology, peripheral expression, and environmental interactions
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Development and Characterisation of a Rat Model of Parkinson's Disease
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
NMR studies on lipid-peptide co-aggregation between ganglioside-containing membranes and α-synuclein
2022)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
α-synuclein interactions with lipid membranes
2022)(
- Thesis › Doctoral thesis (compilation)
- 2021
-
Mark
TNF-α and α-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respiration
(
- Contribution to journal › Article
-
Mark
The intracellular milieu of Parkinson’s disease patient brain cells modulates alpha-synuclein protein aggregation
(
- Contribution to journal › Article
-
Mark
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture
(
- Contribution to journal › Article
-
Mark
DNAJB6 suppresses alpha-synuclein induced pathology in an animal model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
alpha-synuclein: amyloid fibrils and interactions with lipid membranes
2021)(
- Thesis › Doctoral thesis (compilation)
-
Mark
On the Cluster Formation of α-Synuclein Fibrils
(
- Contribution to journal › Article
-
Mark
The bacterial amyloids phenol soluble modulins from staphylococcus aureus catalyze alpha-synuclein aggregation
(
- Contribution to journal › Article
-
Mark
Exploring Patient-Specific Cell Replacement Therapy for Parkinson's Disease
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2020
-
Mark
Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein
(
- Contribution to journal › Article
-
Mark
Protein Quality Control Pathways at the Crossroad of Synucleinopathies
(
- Contribution to journal › Scientific review
-
Mark
Oligodendroglial (dys)function in alpha-synucleinopathies
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2019
-
Mark
Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
How is alpha-synuclein cleared from the cell?
(
- Contribution to journal › Scientific review
-
Mark
Cytosolic Trapping of a Mitochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies
(
- Contribution to journal › Article
-
Mark
Organotypic slice culture model demonstrates inter-neuronal spreading of alpha-synuclein aggregates
(
- Contribution to journal › Article
-
Mark
Cellular alterations identified in pluripotent stem cell-derived midbrain spheroids generated from a female patient with progressive external ophthalmoplegia and parkinsonism who carries a novel variation (p.Q811R) in the POLG1 gene
(
- Contribution to journal › Article
- 2018
-
Mark
α-Synuclein Fibril Formation and the Effects of Lipid Membranes
2018)(
- Thesis › Doctoral thesis (compilation)
-
Mark
In vivo quantification of glial activation in minipigs overexpressing human α-synuclein
(
- Contribution to journal › Article
- 2017
-
Mark
Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes
(
- Contribution to journal › Article
- 2016
-
Mark
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression
(
- Contribution to journal › Article
-
Mark
Pathogenic effects of alpha-synuclein: modifications and toxicity
2016)(
- Thesis › Doctoral thesis (compilation)
-
Mark
A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein
(
- Contribution to journal › Article
- 2015
-
Mark
A Genetic Mouse Model of Parkinson's Disease Shows Involuntary Movements and Increased Postsynaptic Sensitivity to Apomorphine
(
- Contribution to journal › Article
-
Mark
Fluorescent Probes and Protein Misfolding: Methods and Applications
2015)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease
(
- Contribution to journal › Article
- 2014
-
Mark
Alpha-Synuclein Repeat Variants and Survival in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
A porous silicon immunoassay platform for fluorometric determination of alpha-synuclein in human cerebrospinal fluid
(
- Contribution to journal › Article
-
Mark
Anti-amyloid compounds inhibit α-synuclein aggregation induced by protein misfolding cyclic amplification (PMCA)
(
- Contribution to journal › Article
-
Mark
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants
(
- Contribution to journal › Article
- 2013
-
Mark
Cholinergic and dopaminergic aspects of dementia in Parkinson's disease: postmortem neuropathological findings and modeling of cognitive dysfunction in rodents
(
- Thesis › Doctoral thesis (compilation)
-
Mark
What's to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
(
- Contribution to journal › Article
-
Mark
Boosting chaperone-mediated autophagy in vivo mitigates alpha-synuclein-induced neurodegeneration
(
- Contribution to journal › Article
-
Mark
Animal Models of Parkinson's Disease: Limits and Relevance to Neuroprotection Studies
(
- Contribution to journal › Scientific review
-
Mark
LAMP2A as a therapeutic target in Parkinson disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease
(
- Contribution to journal › Article
- 2012
-
Mark
A Pilot Study Examining Associations between DYRK1A and alpha-Synuclein Dementias
(
- Contribution to journal › Article
-
Mark
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.
(
- Contribution to journal › Article
-
Mark
Long-term polarization of microglia upon α-synuclein overexpression in nonhuman primates
(
- Contribution to journal › Article
-
Mark
Altered CSF Orexin and α-Synuclein Levels in Dementia Patients.
(
- Contribution to journal › Article
- 2011
-
Mark
Heredity in Parkinson's disease. From rare mutations to common genetic risk factors.
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Signs of Degeneration in 12-22-Year Old Grafts of Mesencephalic Dopamine Neurons in Patients with Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
GDNF fails to exert neuroprotection in a rat {alpha}-synuclein model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
A deadly spread: cellular mechanisms of α-synuclein transfer.
(
- Contribution to journal › Article
- 2010
-
Mark
Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Does A "Prion-Like" Mechanism Contribute to the Spreading of Neuropathology in Parkinson's Disease?
(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Suppression of Map Kinases Inhibits Microglial Activation and Attenuates Neuronal Cell Death Induced by Alpha-Synuclein Protofibrils
(
- Contribution to journal › Article
- 2008
-
Mark
The effect of alpha-synuclein knockdown on MPP plus toxicity in models of human neurons
(
- Contribution to journal › Article
- 2007
-
Mark
High dose levodopa therapy is not toxic in multiple system atrophy: Experimental evidence
(
- Contribution to journal › Article
- 2002
-
Mark
Ultrastructure of alpha-synuclein-positive aggregations in U373 astrocytoma and rat primary glial cells
(
- Contribution to journal › Article